OPPE
COM:OPPENHEIMER
Oppenheimer & Co. Inc.
- Privately Held
news - Jul 25, 2025 - 12:34
Oppenheimer Hosts Event to Discuss Investment Strategies for LGN
Oppenheimer is hosting an event on July 28-29 to discuss investment strategies for Ligand Pharmaceuticals Inc (LGND). The event focuses on insights and data to enhance investment approaches. Analysts predict an average target price of $143.88 for LGND, with a 5.44% upside from its current price of $136.45. The company reported a 46% revenue increase and a 11% EPS growth in Q1 2025, with a strong cash position and diversified portfolio. However, it faces challenges like a GAAP net loss and competitive pressures.
gurufocus.comnews - Jul 17, 2025 - 08:32
Oppenheimer Reaffirms “Outperform” Rating for Mosaic (NYSE:MOS)
Oppenheimer reaffirmed an 'outperform' rating for Mosaic (NYSE:MOS), raising its price target to $43.00 from $39.00. Multiple analysts upgraded or adjusted ratings, with Mosaic reporting Q2 earnings exceeding expectations. Insider Walter F. Precourt III sold shares, and institutional investors adjusted holdings. The company operates in phosphate and potash production globally.
defenseworld.netnews - Jul 17, 2025 - 02:00
Oppenheimer Reaffirms Outperform Rating for Monolithic Power Systems (NASDAQ:MPWR)
Research analysts at Oppenheimer reaffirmed their 'outperform' rating for Monolithic Power Systems (MPWR), raising their target price to $800 from $700. Multiple analysts, including Needham & Company, Stifel Nicolaus, Raymond James Financial, TD Cowen, and KeyCorp, have issued buy ratings or adjusted target prices. The company reported Q1 earnings of $4.04 EPS, exceeding estimates, with a 39.2% revenue increase year-over-year. MPWR has a market cap of $34.19 billion, P/E ratio of 18.95, and a 1-year price range of $438.86 to $959.64.
defenseworld.netnews - Jul 16, 2025 - 11:02
Oppenheimer Increases Cboe Global Markets (NASDAQ:CBOE) Price Target to $253.00
Oppenheimer raised its price target for Cboe Global Markets (NASDAQ:CBOE) to $253.00 from $249.00, with an 'outperform' rating. Multiple brokerages adjusted their targets, while the company reported strong quarterly earnings and insider trading activity.
marketbeat.comnews - Jul 15, 2025 - 18:14
Oppenheimer Raises KKR & Co. Inc. (NYSE:KKR) Price Target to $162.00
Oppenheimer raised its price target for KKR & Co. Inc. (NYSE:KKR) to $162.00 from $149.00, citing an "outperform" rating. Other analysts, including Morgan Stanley, Keefe, Bruyette & Woods, and Piper Sandler, also updated their ratings and price targets. KKR's stock fell 1.2% to $139.43, with significant institutional holdings and insider transactions reported. The company reported Q1 earnings per share of $1.15, beating estimates, and has a market cap of $124.18 billion.
marketbeat.comDescription
Oppenheimer & Co. Inc. is a global financial institution offering wealth management, capital markets, and investment banking solutions. It provides customized strategies centered on the goals of its clients.